These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25524554)

  • 1. Estrogen receptors β1 and β2 are associated with distinct responses of estrogen receptor α-positive breast carcinoma to adjuvant endocrine therapy.
    Dhimolea E; Tiniakos DG; Chantzi ΝΙ; Goutas N; Vassilaros SD; Mitsiou DJ; Alexis ΜN
    Cancer Lett; 2015 Mar; 358(1):37-42. PubMed ID: 25524554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
    Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
    Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of oestrogen receptor beta 2 (ER beta 2/ER beta cx) with outcome of adjuvant endocrine treatment for primary breast cancer--a retrospective study.
    Vinayagam R; Sibson DR; Holcombe C; Aachi V; Davies MP
    BMC Cancer; 2007 Jul; 7():131. PubMed ID: 17640362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of mRNA for oestrogen receptor beta splice variants ERbeta1, ERbeta2/ERbetacx and ERbeta5 with outcome in endocrine-treated breast cancer.
    Davies MP; O'Neill PA; Innes H; Sibson DR; Prime W; Holcombe C; Foster CS
    J Mol Endocrinol; 2004 Dec; 33(3):773-82. PubMed ID: 15591034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma.
    Chantzi NI; Tiniakos DG; Palaiologou M; Goutas N; Filippidis T; Vassilaros SD; Dhimolea E; Mitsiou DJ; Alexis MN
    J Cancer Res Clin Oncol; 2013 Sep; 139(9):1489-98. PubMed ID: 23817696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid.
    Meligova AK; Siakouli D; Stasinopoulou S; Xenopoulou DS; Zoumpouli M; Ganou V; Gkotsi EF; Chatziioannou A; Papadodima O; Pilalis E; Alexis MN; Mitsiou DJ
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers.
    Yan M; Rayoo M; Takano EA; ; Fox SB
    Breast Cancer Res Treat; 2011 Apr; 126(2):395-405. PubMed ID: 20490651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIES†.
    Speirs V; Viale G; Mousa K; Palmieri C; Reed SN; Nicholas H; Cheang M; Jassem J; Lønning PE; Kalaitzaki E; van de Velde CJH; Rasmussen BB; Verhoeven DM; Shaaban AM; Bartlett JMS; Bliss JM; Coombes RC;
    Ann Oncol; 2015 Sep; 26(9):1890-1897. PubMed ID: 26002610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of estrogen receptor β2 in breast cancer.
    Baek JM; Chae BJ; Song BJ; Jung SS
    Int J Surg; 2015 Feb; 14():17-22. PubMed ID: 25450264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning, characterisation, and expression of three oestrogen receptors (ERalpha, ERbeta1 and ERbeta2) in the European sea bass, Dicentrarchus labrax.
    Halm S; Martínez-Rodríguez G; Rodríguez L; Prat F; Mylonas CC; Carrillo M; Zanuy S
    Mol Cell Endocrinol; 2004 Aug; 223(1-2):63-75. PubMed ID: 15279912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
    Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic predictor of residual risk of recurrence after adjuvant chemotherapy and endocrine therapy in high risk estrogen receptor-positive breast cancers.
    Khan SS; Karn T; Symmans WF; Rody A; Müller V; Holtrich U; Becker S; Pusztai L; Hatzis C
    Breast Cancer Res Treat; 2015 Feb; 149(3):789-97. PubMed ID: 25651779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer.
    Ciucci A; Zannoni GF; Travaglia D; Petrillo M; Scambia G; Gallo D
    Gynecol Oncol; 2014 Feb; 132(2):351-9. PubMed ID: 24378878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.
    Shaaban AM; Green AR; Karthik S; Alizadeh Y; Hughes TA; Harkins L; Ellis IO; Robertson JF; Paish EC; Saunders PT; Groome NP; Speirs V
    Clin Cancer Res; 2008 Aug; 14(16):5228-35. PubMed ID: 18698041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy.
    Schade GR; Holt SK; Zhang X; Song D; Wright JL; Zhao S; Kolb S; Lam HM; Levin L; Leung YK; Ho SM; Stanford JL
    J Urol; 2016 Jun; 195(6):1760-6. PubMed ID: 26804755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ERalpha, PR and ERbeta isoforms in neoadjuvant treated breast cancer.
    Wurster M; Ruoff A; Meisner C; Seeger H; Vogel U; Juhasz-Böss I; Solomayer E; Wallwiener D; Fehm T; Neubauer H
    Oncol Rep; 2010 Sep; 24(3):653-9. PubMed ID: 20664970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor β2 is inversely correlated with Ki-67 in hyperplastic and noninvasive neoplastic breast lesions.
    Chantzi NI; Palaiologou M; Stylianidou A; Goutas N; Vassilaros S; Kourea HP; Dhimolea E; Mitsiou DJ; Tiniakos DG; Alexis MN
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):1057-66. PubMed ID: 24671226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
    Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
    Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different associations of estrogen receptor β isoforms, ERβ1 and ERβ2, expression levels with tumor size and survival in early- and late-onset breast cancer.
    Mandusic V; Dimitrijevic B; Nikolic-Vukosavljevic D; Neskovic-Konstantinovic Z; Kanjer K; Hamann U
    Cancer Lett; 2012 Aug; 321(1):73-9. PubMed ID: 22366496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort.
    Elebro K; Borgquist S; Rosendahl AH; Markkula A; Simonsson M; Jirström K; Rose C; Ingvar C; Jernström H
    Clin Cancer Res; 2017 Feb; 23(3):766-777. PubMed ID: 27810901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.